Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
1165 9 |
Ultima descărcare din IBN: 2022-11-29 23:46 |
Căutarea după subiecte similare conform CZU |
616.12-006.325-07-089 (1) |
Patologia sistemului circulator, a vaselor sanguine. Tulburări cardiovasculare (975) |
SM ISO690:2012 MANOLACHE, Gheorghe, BARNACIUC, Sergiu, MOROZAN, Vladislav, MOSCALU, Vitalie, CUŞNIR, Olga, GUZGAN, Iurie, GHICAVÎI, Nelea, CIUBOTARU, Anatol. Tratamentul chirurgical al tumorilor cardiace. In: Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale, 2017, nr. 3(55), pp. 255-259. ISSN 1857-0011. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale | ||||||
Numărul 3(55) / 2017 / ISSN 1857-0011 | ||||||
|
||||||
CZU: 616.12-006.325-07-089 | ||||||
Pag. 255-259 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
În acest studiu au fost trataţi chirurgical 95 de pacienţi cu tumori cardiace. Diagnoza preoperatorie a fost stabilită analizând evoluţia simptomelor clinice, rezultatele investigaţiilor instrumentale (ecocardiografi a, CT, RMN). Morfologia tumorilor se prezintă în felul următor: mixoame – 80 de cazuri, rabdomioame – 2 cazuri, leiomioame - 2 cazuri, hemangiom – 1 caz, fi brom – 1 caz, mezoepitelioame – 2 cazuri, diferite sarcoame – 7 cazuri. Recidiv al mixomului atrial stâng s-a întâlnit la 2 pacienţi (2,9%), care au fost cu succes reoperaţi. Mortalitatea postoperatorie constituie 7,3% (7 pacienţi), fapt care demonstrează efi cacitatea tratamentului chirurgical |
||||||
Cuvinte-cheie tumori cardiace, diagnostic, tratament chirurgical |
||||||
|
Cerif XML Export
<?xml version='1.0' encoding='utf-8'?> <CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'> <cfResPubl> <cfResPublId>ibn-ResPubl-57913</cfResPublId> <cfResPublDate>2017-07-01</cfResPublDate> <cfVol>55</cfVol> <cfIssue>3</cfIssue> <cfStartPage>255</cfStartPage> <cfISSN>1857-0011</cfISSN> <cfURI>https://ibn.idsi.md/ro/vizualizare_articol/57913</cfURI> <cfTitle cfLangCode='RO' cfTrans='o'>Tratamentul chirurgical al tumorilor cardiace</cfTitle> <cfKeyw cfLangCode='RO' cfTrans='o'>tumori cardiace; diagnostic; tratament chirurgical</cfKeyw> <cfAbstr cfLangCode='RO' cfTrans='o'><p>În acest studiu au fost trataţi chirurgical 95 de pacienţi cu tumori cardiace. Diagnoza preoperatorie a fost stabilită analizând evoluţia simptomelor clinice, rezultatele investigaţiilor instrumentale (ecocardiografi a, CT, RMN). Morfologia tumorilor se prezintă în felul următor: mixoame – 80 de cazuri, rabdomioame – 2 cazuri, leiomioame - 2 cazuri, hemangiom – 1 caz, fi brom – 1 caz, mezoepitelioame – 2 cazuri, diferite sarcoame – 7 cazuri. Recidiv al mixomului atrial stâng s-a întâlnit la 2 pacienţi (2,9%), care au fost cu succes reoperaţi. Mortalitatea postoperatorie constituie 7,3% (7 pacienţi), fapt care demonstrează efi cacitatea tratamentului chirurgical</p></cfAbstr> <cfAbstr cfLangCode='EN' cfTrans='o'><p>In this study is presented 95 patients with heart tumors were surgically treated. The preoperative diagnosis was established by analyzing the evolution of clinical symptoms, the results of instrumental investigations (echocardiography, CT, MRI). The tumor morphology is presented as follows: mixoma - 80 cases, rhabdomyomas - 2 cases, leiomyomas - 2 cases, hemangioma - 1 case, fi broma - 1 case, mezoepiteliomas - 2 cases, different sarcomas - 7 cases. Recurrence of the left atrial mixoma was found in 2 patients (2.9%) who were successfully reoperated. Postoperative mortality is 7.3% (7 patients), demonstrating the efficacy of surgical treatment. </p></cfAbstr> <cfAbstr cfLangCode='RU' cfTrans='o'><p>В этом исследовании представлено 95 пациентов с опухолями сердца, которые были хирургически оперированы. Дооперационный диагноз был установлен путем анализа эволюции клинических симптомов, результатов инструментальных исследований (эхокардиография, КТ, МРТ). Морфология опухоли представлена следующим образом: миксома - 80 случаев, рабдомиомы - 2 случая, лейомиомы - 2 случая, гемангиома - 1 случай, фиброма - 1 случай, мезоэпителиома - 2 случая, разные саркомы - 7 случаев. Повторение левого предсердного миксомы было обнаружено у 2 пациентов (2,9%), которые были успешно переведены в операционную систему. Послеоперационная смертность составляет 7,3% (7 пациентов), что свидетельствует об эффективности хирургического лечения.</p></cfAbstr> <cfResPubl_Class> <cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId> <cfStartDate>2017-07-01T24:00:00</cfStartDate> </cfResPubl_Class> <cfResPubl_Class> <cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId> <cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId> <cfStartDate>2017-07-01T24:00:00</cfStartDate> </cfResPubl_Class> <cfPers_ResPubl> <cfPersId>ibn-person-11353</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2017-07-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-25993</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2017-07-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-11417</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2017-07-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-36723</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2017-07-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-26987</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2017-07-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-17538</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2017-07-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-17822</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2017-07-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-4622</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2017-07-01T24:00:00</cfStartDate> </cfPers_ResPubl> </cfResPubl> <cfPers> <cfPersId>ibn-Pers-11353</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-11353-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2017-07-01T24:00:00</cfStartDate> <cfFamilyNames>Manolache</cfFamilyNames> <cfFirstNames>Gheorghe</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-25993</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-25993-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2017-07-01T24:00:00</cfStartDate> <cfFamilyNames>Barnaciuc</cfFamilyNames> <cfFirstNames>Sergiu</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-11417</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-11417-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2017-07-01T24:00:00</cfStartDate> <cfFamilyNames>Morozan</cfFamilyNames> <cfFirstNames>Vladislav</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-36723</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-36723-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2017-07-01T24:00:00</cfStartDate> <cfFamilyNames>Moscalu</cfFamilyNames> <cfFirstNames>Vitalie</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-26987</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-26987-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2017-07-01T24:00:00</cfStartDate> <cfFamilyNames>Cuşnir</cfFamilyNames> <cfFirstNames>Olga</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-17538</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-17538-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2017-07-01T24:00:00</cfStartDate> <cfFamilyNames>Guzgan</cfFamilyNames> <cfFirstNames>Iurie</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-17822</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-17822-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2017-07-01T24:00:00</cfStartDate> <cfFamilyNames>Ghicavîi</cfFamilyNames> <cfFirstNames>Nelea</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-4622</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-4622-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2017-07-01T24:00:00</cfStartDate> <cfFamilyNames>Ciubotaru</cfFamilyNames> <cfFirstNames>Anatol</cfFirstNames> </cfPersName_Pers> </cfPers> </CERIF>